Grifols Therapeutics Llc
Clinical trials sponsored by Grifols Therapeutics Llc, explained in plain language.
-
New shot option for nerve disease? study tests weekly vs IV treatment
Disease control Recruiting nowThis study compares two medicines for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), a nerve disorder. It aims to see if XEMBIFY, given as a weekly shot under the skin, provides similar drug levels as Gamunex-C, given into a vein every 3 weeks. About 40 adults …
Phase: PHASE3 • Sponsor: Grifols Therapeutics LLC • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC
-
New hope for blood cancer patients: drug aims to cut Life-Threatening infections
Prevention Recruiting nowThis study tests whether a medicine called XEMBIFY, given every two weeks along with standard care, can reduce serious bacterial infections in adults with certain blood cancers (chronic lymphocytic leukemia, multiple myeloma, or non-Hodgkin lymphoma) who also have low antibody le…
Phase: PHASE3 • Sponsor: Grifols Therapeutics LLC • Aim: Prevention
Last updated May 17, 2026 15:14 UTC